| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.23 | 2e-11 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-11 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.21 | 1e-10 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-08 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.15 | 6e-07 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.17 | 6e-07 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.15 | 1e-06 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.23 | 1e-05 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |